Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS
Carlo Lavalle, Nicola Pierucci, Marco Valerio Mariani, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 6
Closed Access | Times Cited: 14
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
Marco Valerio Mariani, Nicola Pierucci, Agostino Piro, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1513-1513
Open Access | Times Cited: 26
Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Yunwen Xu, Alex R. Chang, Lesley A. Inker, et al.
Circulation (2023) Vol. 148, Iss. 19, pp. 1445-1454
Closed Access | Times Cited: 16
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
Cristina Chimenti, Carlo Lavalle, Michele Magnocavallo, et al.
ESC Heart Failure (2021) Vol. 9, Iss. 1, pp. 241-250
Open Access | Times Cited: 32
Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion
Domenico G. Della Rocca, Michele Magnocavallo, Christoffel J. van Niekerk, et al.
EP Europace (2023) Vol. 25, Iss. 11
Open Access | Times Cited: 11
Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score–matched comparison with direct oral anticoagulant
Michele Magnocavallo, Domenico G. Della Rocca, Giampaolo Vetta, et al.
Heart Rhythm (2024) Vol. 21, Iss. 8, pp. 1267-1276
Closed Access | Times Cited: 4
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Hemodialysis
Lukas Urbanek, Gunnar H. Heine, Claudia Reddavid, et al.
JACC. Clinical electrophysiology (2025) Vol. 11, Iss. 1, pp. 71-82
Closed Access
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Chronic Kidney Disease Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
Rosauro Mejia, Arminder Singh, Amol Bahekar, et al.
Cureus (2025)
Open Access
Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review
Heitor Martins de Oliveira, Lorrany Pereira Barros, Maria Clara Azzi Vaz de Campos, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
The Prevalence and Burden of Chronic Kidney Disease, Patterns of Anticoagulation Prescribing, and Major Bleeding Risk in Older Adults with Atrial Fibrillation
Hawa O. Abu, Francisco Castillo, Weijia Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Blood urea nitrogen to serum albumin ratio as a prognostic marker for 28-day mortality in atrial fibrillation: a retrospective cohort study
Yun Huang, Guangdong Wang, Xiang Xia, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets
Paolo Severino, Andrea D’Amato, Silvia Prosperi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7650-7650
Open Access | Times Cited: 22
Bleeding disorders in implant dentistry: a narrative review and a treatment guide
Paul Römer, Diana Heimes, Andreas Pabst, et al.
International Journal of Implant Dentistry (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
Yunwen Xu, Alex R. Chang, Lesley A. Inker, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 14
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation
Luca Di Lullo, Carlo Lavalle, Michele Magnocavallo, et al.
International Journal of Cardiology (2021) Vol. 345, pp. 90-97
Closed Access | Times Cited: 17
Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics
Lorenzo E. Thompson, Brittney H. Davis, Renuka Narayan, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 3, pp. 585-599
Open Access | Times Cited: 12
Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Yunwen Xu, Shoshana H. Ballew, Alex R. Chang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 2
Atrial Fibrillation and Anticoagulant Treatment in End-Stage Renal Disease Patients: Where Do We Stand?
Luca Di Lullo, Marco Valerio Mariani, Claudio Ronco, et al.
Cardiorenal Medicine (2022) Vol. 12, Iss. 4, pp. 131-140
Open Access | Times Cited: 11
Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches
Leona A. Verma, Peter E. Penson, Asangaedem Akpan, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 12, pp. 963-983
Open Access | Times Cited: 6
Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease
Pajaree Krisanapan, Pattharawin Pattharanitima, Charat Thongprayoon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4653-4653
Open Access | Times Cited: 8
Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
Wenhao Li, Yanxia Zhou, Siqi Chen, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry
Giuseppe Boriani, Raffaele De Caterina, Marius Constantin Manu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2879-2879
Open Access | Times Cited: 10
Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
Carlo Lavalle, Marco Valerio Mariani, Agostino Piro, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3207-3207
Open Access | Times Cited: 6
The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
Jelena Šimić, M Mihajlović, Nevena Zec, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 12, pp. 937-945
Closed Access | Times Cited: 3
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min
Lauren Cline, Erika Marie G. Generoso, Nicholas D’Apice, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 55, Iss. 2, pp. 355-364
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top